本頁面由Tiger Trade Technology Pte. Ltd.提供服務

C4 Therapeutics, Inc.

3.42
-0.0350-1.01%
盤前3.680.2635+7.72%06:53 EDT
成交量:175.82萬
成交額:605.29萬
市值:4.20億
市盈率:-3.76
高:3.59
開:3.51
低:3.40
收:3.45
52周最高:5.17
52周最低:1.69
股本:1.23億
流通股本:9,451.50萬
量比:1.13
換手率:1.86%
股息:- -
股息率:- -
每股收益(TTM):-0.9085
每股收益(LYR):-1.2666
淨資產收益率:-48.14%
總資產收益率:-19.25%
市淨率:1.70
市盈率(LYR):-2.70

資料載入中...

2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/07/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/24

重要事件披露

Form 8-K - Current report
2026/06/11

重要事件披露

Form 8-K - Current report
2026/05/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/19

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]